Claremont Creek Ventures Sees An Uptick In Corporate Venture Capital: Interest Leverages Growth For Portfolio Companies

By Nat Goldhaber / July 6, 2011 / 0 Comments

I was chatting recently with Venture Capital Journal’s Mark Boslet about a story concerning corporate venture capital investing and realized that Claremont Creek Ventures is among those VC firms witnessing first-hand heightened interest among corporations investing in venture-backed startups. We’re seeing activity, in particular, in healthcare and in clean technology, and it’s a good thing. […]

Read More

What Does It Take to Swing the IPO Window Open for Biotechs? – Suggestions include selling at a discount at a time when there is a rising investor fan-base for social media.

By Claremont Creek Alerts / June 22, 2011 / 0 Comments

June 22, 2011  source: Genetic Engineering and Biotechnology News On June 10, a day after withdrawing an $86 million IPO filed in November 2010, Ambit Biosciences reported securing $30 million in Series D-2 equity financing. “The terms currently obtainable in the public marketplace are not sufficiently attractive to the registrant to warrant proceeding with the […]

Read More

Further musings on TMI and Fukushima in the Mercury News

By Claremont Creek Alerts / June 10, 2011 / 0 Comments

Q&A with Nat Goldhaber on the Three Mile Island crisis By Peter Delevett Mercury News Columnist Nat Goldhaber may have the most offbeat resume of any venture capitalist in Silicon Valley. In early 1979, he was a few weeks into a job running energy policy for Pennsylvania’s new governor — a post for which he cheerfully […]

Read More

The Argument for the Secondary Market

By Randy Hawks / February 16, 2011 / 0 Comments

February 16, 2011  source: this guest blog post originally appeared on peHUB There has been a lot of buzz around highflying companies allowing sales of their stock on secondary trading platforms. There have always been opportunities for individual secondary sales in private companies but nothing to match the current level of action. Before, occasional private […]

Read More

Creating Value In A World of Big Data

By Ted Driscoll / February 6, 2011 / 3 Comments

When I was in high school back in the 70’s, I remember my favorite physics teacher telling me about the difference between data and information. Data was raw, unprocessed and unlinked to any meaning. Information was what data became when it was linked to meaning. This was an important distinction that has even greater meaning […]

Read More

Nat Goldhaber comments on cleantech and effects of cuts in CA education funding

By Claremont Creek Alerts / January 13, 2011 / 0 Comments

January 13, 2011 source: VentureBeat and Bloomberg Nat Goldhaber was recently quoted in news articles about Cleantech trends and the potential repercussions of impending budget cuts for California education.   Cleantech’s blockbuster $234 billion year: What’s next? VentureBeat A good year for IPOs, possibly maybe — This is debatable, but at least one VC, Nat […]

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat_Boldhaber7718 -1200px


Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

Brad_Webb8124 1200px crop


Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

Randy_Hawks7690 -1200px


Randy Hawks is a co-founder of Claremont Creek Ventures.

Post Categories